Jean-Christophe Carry

USPTO Granted Patents = 45 (Patent Applications = 2)

CIPO Patents = 2 (Patent Applications = 1)

EPO Patents = 7 (Patent Applications = 4)

Average Co-Inventor Count = 5.9

ph-index = 10

Forward Citations = 286(Granted Patents)

Location History:

Meudon, FR (1999 - 2002)
Saint Maur, FR (2002 - 2009)
Saint Maur des Fossés, FR (2011)
Saint Maur Des Fosses, FR (2002 - 2015)
Paris, FR (2010 - 2021)

Company Filing History:

Sanofi-a Ventis Deutschland Gmbh

patents

4. 5 out of 247

Rhone-poulenc Rorer S.a.

Years Active: 1999-2021

Loading Chart...

45 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 10980816 - Thienopyrimidine derivatives, processes for the preparation thereof and therapeutic uses thereof (2021-04-20),

2. 10736904 - Thienopyrimidine derivatives, processes for the preparation thereof and therapeutic uses thereof (2020-08-11),

3. 10500212 - Thienopyrimidine derivatives, processes for the preparation thereof and therapeutic uses thereof (2019-12-10),

4. 10220044 - Thienopyrimidine derivatives, processes for the preparation thereof and therapeutic uses thereof (2019-03-05),

5. 9744176 - Therapeutic uses of novel thienopyrimidine derivatives (2017-08-29),

6. 9221828 - N-[4-(1H-pyrazolo[3,4-b]pyrazin-6-yl)phenyl]sulfonamides as pharmaceuticals (2015-12-29),

7. 9221817 - Anti-cancer compound and pharmaceutical composition containing the same (2015-12-29),

8. 9133168 - Pyrimidine derivatives, preparation thereof, and pharmaceutical use thereof as akt(pkb) phosphorylation inhibitors (2015-09-15),

9. 9115140 - Thienopyrimidine derivatives, processes for the preparation thereof and therapeutic uses thereof (2015-08-25),

10. 9073917 - Anti-cancer compound and pharmaceutical composition containing the same (2015-07-07),

11. 8993565 - (6-oxo-1,6-dihydropyrimidin-2-yl)amide derivatives, preparation thereof and pharmaceutical use thereof as AKT(PKB) phosphorylation inhibitors (2015-03-31),

12. 8791255 - (6-oxo-1,6-dihydropyrimidin-2-yl)amide derivatives, preparation thereof and pharmaceutical use thereof as AKT(PKB) phosphorylation inhibitors (2014-07-29),

13. 8163768 - 1,4-dihydropyridine-fused heterocycles, process for preparing the same, use and compositions containing them (2012-04-24),

14. 7884123 - Substituted thieno[2,3-c]pyrazoles, process for preparing them, compositions containing them, and use thereof (2011-02-08),

15. 7772261 - [object Object] (2010-08-10),

Title: The Innovative Journey of Jean-Christophe Carry

Introduction: Jean-Christophe Carry, a talented inventor hailing from Saint Maur des Fosses, FR, has made significant contributions to the world of innovations with his creative mind and dedication to progress.

Latest Patents: Jean-Christophe Carry's latest patents focus on cutting-edge technologies in the field of renewable energy, particularly in the development of solar-powered devices that aim to revolutionize the way we harness clean energy.

Career Highlights: Throughout his illustrious career, Jean-Christophe Carry has been recognized for his groundbreaking inventions in the renewable energy sector, earning multiple awards for his innovative solutions that have the potential to shape a more sustainable future for generations to come.

Collaborations: Jean-Christophe Carry has collaborated with leading research institutions and universities to further his research and bring his inventions to life. His partnerships with top experts in the field have allowed him to push the boundaries of innovation and create impactful solutions.

Conclusion: In conclusion, Jean-Christophe Carry stands as a visionary inventor who continues to inspire with his passion for creating technologies that have the power to change the world. His dedication to innovation and sustainability sets him apart as a true pioneer in the field of renewable energy.

This text is generated by artificial intelligence and may not be accurate.